Key facts
- This page summarizes Jack Kendrick Heilbron's Form 4 filing for CONDUIT PHARMACEUTICALS INC. (CDT).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Sep 2023, 17:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Other
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Other
Additional SEC filing notes
Section 16 status
Jack Kendrick Heilbron is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Upon consummation of the issuer's initial business combination (the "IBC"), the issuer's shares of Class B common stock were converted into shares of Class A common stock and the shares of Class A common stock were then reclassified as a single class of common stock.
Footnote F2
Includes (i) 3,306,250 shares of common stock due to the conversion of the shares of Class B common stock into shares of Class A common stock and then reclassification into shares of Company common stock and (ii) 754,000 shares of common stock, which prior to the IBC were shares of Class A common stock.
Footnote F3
Held by Murphy Canyon Acuqisition Sponsor, LLC (the "Sponsor"). Jack K. Heilbron is the President of the Managing Member of the Sponsor. Mr. Heilbron disclaims any such beneficial ownership except to the extent of his pecuniary interest. Mr. Heilbron resigned as Chief Executive Officer and Chairman of the issuer upon the consummation of the IBC.
Footnote F4
Immediately following the consummation of the IBC, Murphy Canyon Acquisition Sponsor, LLC transferred 45,000 shares of common stock as consideration for their services to three directors, two of whom had resigned upon consummation of the IBC.
Footnote F5
Includes (i) 3,306,250 shares of common stock due to the conversion of the shares of Class B common stock into shares of Class A common stock and then reclassification into shares of Company common stock and (ii) 709,000 shares of common stock, which prior to the IBC were shares of Class A common stock.
Footnote F6
Includes 754,000 shares of common stock, which prior to the IBC were shares of Class A common stock.
Footnote F7
Immediately following the consummation of the IBC, Murphy Canyon Acquisition Sponsor, LLC transferred 45,000 warrants as consideration for their services to three directors, two of whom had resigned upon consummation of the IBC.
Footnote F8
Includes 709,000 shares of common stock, which prior to the IBC were shares of Class A common stock.